The Effect of Peer Comparison Emails on Oncologists' Documentation of Cancer Stage
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04298762|
Recruitment Status : Completed
First Posted : March 6, 2020
Last Update Posted : March 6, 2020
|Condition or disease||Intervention/treatment||Phase|
|Oncology||Other: No peer comparison email Other: Peer comparison email||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||56 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||The Effect of Peer Comparison Emails on Oncologists' Documentation of Cancer Stage|
|Actual Study Start Date :||July 1, 2018|
|Actual Primary Completion Date :||September 30, 2019|
|Actual Study Completion Date :||September 30, 2019|
Placebo Comparator: Comparison Group
Physicians in the control group did not receive peer comparison emails.
Other: No peer comparison email
The comparison group received no email communication on their cancer stage documentation activity.
Experimental: Intervention Group
Physicians in the intervention group received peer comparison emails.
Other: Peer comparison email
The intervention group received three separate emails with individualized data on their cancer stage documentation activity in the previous 1-3 months. The email described the number and percent of attributed patients for whom cancer stage was documented, and included a figure showing their staging documentation rate compared to their peers.
- Measuring if a patient's cancer stage was documented in a structured field in the Electronic Health Record on the date of the patient's first ambulatory care visit [ Time Frame: 15 months ]Indicator of whether the structured field for cancer stage in the patient's electronic health record (EHR) was populated on the date of the first outpatient encounter that a patient had during the study period (1=yes, 0=no)
- Staging documentation rate (monthly) [ Time Frame: 15 months ]Percentage of patients whose first outpatient encounter occurred in a given month for whom cancer stage was documented
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04298762
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Anna Sinaiko, PhD||Harvard School of Public Health|